Brands: Concerta · Relexxii · Methylphenidate Hydrochloride
Average across 41 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | unknown | 11 | SUPPLYING |
| Trigen Laboratories, LLC | unknown | 8 | SUPPLYING |
| Lannett Company, Inc. | generic | 8 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 6 | SUPPLYING |
| Golden State Medical Supply, Inc. | repackager | 6 | SUPPLYING |
| SpecGx LLC | unknown | 5 | SUPPLYING |
| XLCare Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 4 | SUPPLYING |
| Janssen Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| American Health Packaging | repackager | 4 | SUPPLYING |
| Granules Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 2 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 1 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 1 | EXITED 2026 |
Shortages, recalls, and registration changes attached to this drug concept.
Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications. — Recalling firm: Trigen Laboratories — Nationwide in the USA
Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Janssen Pharmaceuticals. Therapeutic category: Psychiatry.
Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Lannett Company, Inc.. Therapeutic category: Psychiatry.
Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Trigen Laboratories, LLC. Therapeutic category: Psychiatry.
Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Sun Pharmaceutical Industries, Inc.. Therapeutic category: Psychiatry.
Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Vertical Pharmaceuticals, LLC. Therapeutic category: Psychiatry.
Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet. — Recalling firm: Osmotica Pharmaceutical Corp — Nationwide in the USA
Subpotent Drug — Recalling firm: Osmotica Pharmaceutical Corp — Nationwide
Subpotent Drug — Recalling firm: Osmotica Pharmaceutical Corp — Nationwide
